FDA Inspection 1177713 — Missouri Center For Reproductive Medicine, LLC
The FDA completed an inspection of Missouri Center For Reproductive Medicine, LLC on Jul 14, 2022 in Tulsa, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 14, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Tulsa, OK (United States)